(1)
A Pilot Study, to Evaluate the Safety and Efficacy of Topically Applied Onabotulinum Toxin A Delivered through a Novel Iontophoresis Device in Subjects With Axillary Hyperhidrosis. J of Skin 2022, 6 (6), s106. https://doi.org/10.25251/skin.6.supp.106.